BIOSECURE Act set for Congress vote after inclusion in annual defence bill
If passed into law, the BIOSECURE Act would have a major impact on US-China relationships in the pharma industry.
Business & Regulation
Former FDA commissioners unite to condemn US vaccine proposals
House passes bill that reauthorises the FDA’s paediatric priority voucher pathway
UK and US strike “landmark” zero-tariff pharma deal
Novo Nordisk latest outlook trim shows “quick momentum loss”
Tidmarsh’s FDA exit marks latest high-profile jockeying at US agencies
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
Massive sales for weight loss drugs spur Eli Lilly’s Q3
